CRISPR Therapeutics AG (CRSP)
55.08
+2.70
(+5.15%)
USD |
NASDAQ |
May 06, 16:00
55.00
-0.08
(-0.15%)
After-Hours: 07:02
CRISPR Therapeutics Shareholders Equity (Quarterly) : 1.815B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 19.36B |
| Beam Therapeutics, Inc. | 1.238B |
| Novartis AG | 38.51B |
| EvoNext Holdings SA | -- |
| Kuros Biosciences Ltd. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.726B |
| Total Liabilities (Quarterly) | 911.26M |
| Debt to Equity Ratio | 0.4341 |
| Current Ratio | 17.96 |
| Net Debt Paydown Yield | -2.46% |